View in EDS HTML Full Text PDF Full Text

Redo craniotomy or bevacizumab for symptomatic steroid-refractory true or pseudoprogression following IMRT for glioblastoma.

Saved in:
Bibliographic Details
Title: Redo craniotomy or bevacizumab for symptomatic steroid-refractory true or pseudoprogression following IMRT for glioblastoma.
Authors: Cook TA; Central Coast Cancer Centre, Gosford Hospital, Gosford, New South Wales, Australia., Jayamanne DT; Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, New South Wales, Australia., Wheeler HR; Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, New South Wales, Australia.; Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia., Wong MHF; Central Coast Cancer Centre, Gosford Hospital, Gosford, New South Wales, Australia., Parkinson JF; Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.; The Brain Cancer Group, Sydney, New South Wales, Australia.; Department of Neurosurgery, Royal North Shore Hospital, Sydney, New South Wales, Australia., Cook RJ; Department of Neurosurgery, Royal North Shore Hospital, Sydney, New South Wales, Australia., Kastelan MA; Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, New South Wales, Australia.; The Brain Cancer Group, Sydney, New South Wales, Australia., Cove NJ; Central Coast Cancer Centre, Gosford Hospital, Gosford, New South Wales, Australia., Brown C; Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, New South Wales, Australia., Back MF; Central Coast Cancer Centre, Gosford Hospital, Gosford, New South Wales, Australia.; Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, New South Wales, Australia.; Genesis Cancer Care, Sydney, New South Wales, Australia.; Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.; The Brain Cancer Group, Sydney, New South Wales, Australia.
Source: Neuro-oncology practice [Neurooncol Pract] 2021 Jun 09; Vol. 8 (5), pp. 601-608. Date of Electronic Publication: 2021 Jun 09 (Print Publication: 2021).
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 101640528 Publication Model: eCollection Cited Medium: Print ISSN: 2054-2577 (Print) Linking ISSN: 20542577 NLM ISO Abbreviation: Neurooncol Pract Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34594572
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Redo craniotomy or bevacizumab for symptomatic steroid-refractory true or pseudoprogression following IMRT for glioblastoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Cook+TA%22">Cook TA</searchLink>; Central Coast Cancer Centre, Gosford Hospital, Gosford, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Jayamanne+DT%22">Jayamanne DT</searchLink>; Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Wheeler+HR%22">Wheeler HR</searchLink>; Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, New South Wales, Australia.; Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Wong+MHF%22">Wong MHF</searchLink>; Central Coast Cancer Centre, Gosford Hospital, Gosford, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Parkinson+JF%22">Parkinson JF</searchLink>; Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.; The Brain Cancer Group, Sydney, New South Wales, Australia.; Department of Neurosurgery, Royal North Shore Hospital, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Cook+RJ%22">Cook RJ</searchLink>; Department of Neurosurgery, Royal North Shore Hospital, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Kastelan+MA%22">Kastelan MA</searchLink>; Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, New South Wales, Australia.; The Brain Cancer Group, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Cove+NJ%22">Cove NJ</searchLink>; Central Coast Cancer Centre, Gosford Hospital, Gosford, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Brown+C%22">Brown C</searchLink>; Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Back+MF%22">Back MF</searchLink>; Central Coast Cancer Centre, Gosford Hospital, Gosford, New South Wales, Australia.; Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, New South Wales, Australia.; Genesis Cancer Care, Sydney, New South Wales, Australia.; Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.; The Brain Cancer Group, Sydney, New South Wales, Australia.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101640528%22">Neuro-oncology practice</searchLink> [Neurooncol Pract] 2021 Jun 09; Vol. 8 (5), pp. 601-608. <i>Date of Electronic Publication: </i>2021 Jun 09 (<i>Print Publication: </i>2021).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101640528 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2054-2577 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220542577%22">20542577 </searchLink><i>NLM ISO Abbreviation: </i>Neurooncol Pract <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34594572
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/nop/npab034
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 601
    Titles:
      – TitleFull: Redo craniotomy or bevacizumab for symptomatic steroid-refractory true or pseudoprogression following IMRT for glioblastoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Cook TA
      – PersonEntity:
          Name:
            NameFull: Jayamanne DT
      – PersonEntity:
          Name:
            NameFull: Wheeler HR
      – PersonEntity:
          Name:
            NameFull: Wong MHF
      – PersonEntity:
          Name:
            NameFull: Parkinson JF
      – PersonEntity:
          Name:
            NameFull: Cook RJ
      – PersonEntity:
          Name:
            NameFull: Kastelan MA
      – PersonEntity:
          Name:
            NameFull: Cove NJ
      – PersonEntity:
          Name:
            NameFull: Brown C
      – PersonEntity:
          Name:
            NameFull: Back MF
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 09
              M: 06
              Text: 2021 Jun 09
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-print
              Value: 2054-2577
          Numbering:
            – Type: volume
              Value: 8
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Neuro-oncology practice
              Type: main
ResultId 1